Use Mounjaro and Ozempic are both FDA approved for glycemic control in adults with type 2 diabetes, in combination with diet and exercise
In the SURMOUNT-1 clinical trial, individuals with overweight/obesity without diabetes taking tirzepatide (5 mg, 10 mg, and 15 mg once weekly) lost 16%, 21.4%, and 22.5% of body weight, respectively, after 72 weeks
Call (925) 694-0248 to speak with local Pleasanton, California Peptide Specialists at Audra Foster, N.D
Metabolic Benefits Beyond Weight Loss Beyond just weight and blood sugar control, GLP-1 medications have additional health benefits: Reduced inflammation : GLP-1 agonists have anti-inflammatory effects, which is beneficial for heart health and reducing the risk of chronic diseases
Liver damage may prevent proper hormone processing, lessening the medications benefits
Many patients report eating smaller portions and feeling satisfied sooner, though the scale may show only modest changes initially